These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statistical characteristics of the USP content uniformity test. Pedersen AO; Torud Y Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661 [No Abstract] [Full Text] [Related]
4. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets]. Tao QF; Zhong DF; Luo X; Wang X Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209 [No Abstract] [Full Text] [Related]
6. Comparison of dissolution profiles of tablets and capsules from the USP, Levy, and magnetic basket methods. Needham TE; Luzzi LA J Pharm Sci; 1974 Jun; 63(6):925-8. PubMed ID: 4851107 [No Abstract] [Full Text] [Related]
7. Statistical analysis of the USP 18 content uniformity sampling plan for tablets. Langenbucher F Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143 [No Abstract] [Full Text] [Related]
8. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations. Senderak ET Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989 [TBL] [Abstract][Full Text] [Related]
9. Content uniformity and assay requirements in current regulations. Bánfai B; Ganzler K; Kemény S J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871 [TBL] [Abstract][Full Text] [Related]
10. A mini review of scientific and pharmacopeial requirements for the disintegration test. Donauer N; Löbenberg R Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916 [TBL] [Abstract][Full Text] [Related]
11. Automation of nf method i-usp dissolution-rate test. Beyer WF; Smith EW J Pharm Sci; 1971 Oct; 60(10):1556-9. PubMed ID: 5129374 [No Abstract] [Full Text] [Related]
12. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test. Clapp FL Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566 [No Abstract] [Full Text] [Related]
13. Noninvasive authentication of pharmaceutical products through packaging using spatially offset Raman spectroscopy. Eliasson C; Matousek P Anal Chem; 2007 Feb; 79(4):1696-701. PubMed ID: 17297975 [TBL] [Abstract][Full Text] [Related]
14. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities. Williams RL; ; J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277 [TBL] [Abstract][Full Text] [Related]
15. Identification of counterfeit drugs, particularly barbiturates and amphetamines by microscopic, chemical, and instrumental techniques. Eisenberg WV; Tillson AH J Forensic Sci; 1966 Oct; 11(4):529-51. PubMed ID: 5339648 [No Abstract] [Full Text] [Related]
16. Pharmacopeial standards and specifications for bulk drugs and solid oral dosage forms. Similarities and differences. French WN; Matsui F; Cook D; Levi L J Pharm Sci; 1967 Dec; 56(12):1622-41. PubMed ID: 5588715 [No Abstract] [Full Text] [Related]
17. Pharmaceutical analysis: key to drug quality and control. Florey KG; Brewer GA Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related]
18. [Non-aqueous protometry as a pharmacopeia method of drug analysis]. Safarík L; Kasová M Pharmazie; 1984 Dec; 39(12):843-52. PubMed ID: 6531393 [No Abstract] [Full Text] [Related]
19. [Preparations of the F.N. Farmacopea Nationale containing bismuth. II]. Carlassare M Boll Chim Farm; 1977 Feb; 116(2):116-23. PubMed ID: 861079 [No Abstract] [Full Text] [Related]